Jump to Main Content
Stevia rebaudiana targeting α-amylase: An in-vitro and in-silico mechanistic study
- Singla, Ramit, Singla, Navdeep, Jaitak, Vikas
- Natural product research 2019 v.33 no.4 pp. 548-552
- Stevia rebaudiana, adverse effects, alpha-amylase, diabetes mellitus, drugs, enzyme inhibition, lead, pharmacology, secondary metabolites, therapeutics
- Diabetes mellitus (DM) is the fastest growing metabolic disorder in the world. Recently, more attention is paid to the study of natural products due to side effects of synthetic drugs. Stevia rebaudiana (Bertoni) is considered an encouraging starting point for the antidiabetic lead development. In the present study, the in vitro α-amylase inhibitory activity of the extracts of S. rebaudiana is investigated. In order to understand the molecular mechanism and future pharmacophore development, in silico study of secondary metabolites isolated from S. rebaudiana was carried out. Results indicated that water extract shows highest α-amylase inhibitory activity as compared to other extracts. Moreover, compound 20 (rebaudioside A) which has been previously reported and isolated from water extract showed the impressive binding profile with α-amylase. Therefore, our study suggests that S. rebaudiana could be used in the development of therapeutic drugs for the treatment of diabetes.